Search Results 171-180 of 17069 for pharmacogenetics
The American Heart Association gives guidance on CYP2C19 genetic-guided testing for prescribing blood thinner drugs. A Mayo Clinic cardiologist chaired the ...
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers six main PKD services for research and tools for polycystic kidney disease.
The study also aims to describe similarities and differences among diverse individuals (by self-identified race and ethnicity) regarding concepts of family ...
This diagram illustrates epigenetic writers, readers and erasers of histone H3 lysine 36 methylation, their links to human disease and cancer, ...
In this procedure, specialists aim to fix or replace a faulty gene to try to cure a disease or make the body better able to fight a disease.
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
Application and admissions information for the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.
NGS is a procedure that looks at all of your genes (the genetic material you have inherited from your parents). In this study, we want to collect detailed ...
Lennon provided statistical expertise for a large pharmacogenetics clinical trial conducted at 40 centers worldwide. He helped plan the trial and played a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!